Enzyme for protein synthesis: the role of peptidyl-transferase

Picture of Ainoa Escrich
Ainoa Escrich

04 Dec 2025

Protein synthesis is one of the cell’s most intensive and finely regulated metabolic processes. At the heart of this machinery lies the peptidyl-transferase enzyme, the ribosome’s catalytic center responsible for creating the peptide bond that links amino acids and builds the polypeptide chain. In this article, we review what happens during translation, why this enzyme is pivotal, and how we can leverage this knowledge in biotechnology and ingredient formulation. 

What is protein synthesis? 

Protein synthesis is the stepwise assembly of amino acids on the ribosome using the information encoded in mRNA. It comprises three main phases: 
  • Initiation: the ribosome recognizes the start site on the mRNA, the initiator tRNA is positioned in the P site, and the reading frame is established. 
  • Elongation: aminoacyl-tRNAs sequentially enter the A site. The peptidyl-transferase enzyme catalyzes peptide-bond formation between the peptide in the P site and the amino acid in the A site. After each reaction, the ribosome translocates by one codon and the growing peptide shifts from A to P. 
  • Termination: upon reaching a stop codon, release factors promote hydrolysis of the peptidyl-tRNA, the protein is released, and the ribosome is recycled 

Enzyme for protein synthesis: Importance of peptidyl-transferase  

The peptidyl-transferase enzyme is a catalytic activity of ribosomal RNA located in the large subunit. Its core function is to form the peptide bond via a transesterification reaction between the ?-amino group of the A-site aa-tRNA and the carbonyl of the P-site peptidyl-tRNA. Why is it so important in this process? 
  • Speed and productivity: it determines the elongation rate and, therefore, the protein output of the cell or bioprocess. 
  • Indirect fidelity: while codon–anticodon recognition occurs in the small subunit, the geometry of the peptidyl-transferase center (PTC) favors correctly paired substrates and discourages off-pathway intermediates. 
  • Evolution and universality: the structural conservation of the PTC underscores its evolutionary antiquity and its role as the nucleus of the translational machinery. 
By optimizing this key step in translation, we increase the efficiency and quality of proteins, peptides, and enzymes that enable selective, sustainable routes to high-value ingredients and bioactive compoundsa direct outcome of fine-tuning the enzyme for protein synthesis. 

Protein synthesis: catalytic mechanism 

  1. Accommodation: the correctly paired aa-tRNA in the A site rotates and is precisely positioned. 
  2. Nucleophilic activation: the A-site ?-amino group acts as a nucleophile and attacks the carbonyl of the ester in the peptidyl-tRNA. 
  3. Transition state: the PTC stabilizes the tetrahedral intermediate through hydrogen-bond networks and steric pre-organization; ions such as Mg²? contribute to stabilization. 
  4. Resolution: the peptide is transferred to the A-site tRNA, the deacylated P-site tRNA is released, and the ribosome translocates. 
  5. Cycle: repetition of the elongation cycle extends the polypeptide until a stop codon is reached. 

Structure and molecular basis: peptidyl-transferase enzyme 

  • PTC architecture: a densely structured rRNA cavity where the 3? ends of the P- and A-site tRNAs converge. rRNA bases define the catalytic environment. 
  • Exit tunnel: a channel that guides the nascent chain outward; its microenvironment influences translational pausing and interactions with macrolides. 
  • Conservation and variation: the topology of the PTC is highly conserved across bacteria, archaea, eukaryotes, and mitochondrial ribosomes; subtle differences explain antibiotic selectivity and resistance phenomena. 

Practical applications: formulation and processing 

Precise control of protein synthesis, and in particular of the peptidyl-transferase enzyme during elongation, has a direct impact on the yieldpurity, and functionality of proteins and peptides used to develop high-valueingredients and bioactive compounds. Compuestos bioactivos Funded by the aid program for hiring young professionals specialized in internationalization  
Share this article
Picture of Ainoa Escrich
Ainoa Escrich

Técnico en Biotecnología Industrial

Hola, soy Ainoa Escrich, doctora en Biomedicina por la Universidad Pompeu Fabra (2021), donde me especialicé en la obtención de compuestos bioactivos derivados de plantas y microorganismos. Mi trayectoria académica comenzó con el grado en Biotecnología por la Universidad de Valencia (2011), y posteriormente completé el máster en Biotecnología, Genómica y Biología Celular en la Universitat Autònoma de Barcelona (2017). A lo largo de mi carrera he tenido la oportunidad de realizar varias estancias en el extranjero, lo que me ha permitido ampliar mi visión científica y colaborar en proyectos internacionales. Además, he participado en diversos congresos y publicado varios artículos científicos relacionados con mis líneas de investigación.  

Interested in this topic?

Leave us your details and we will contact you to answer your questions or continue the conversation.

Ainoa Escrich
Técnico en Biotecnología Industrial

Related news

Access to AINIA Network

This area is exclusive to AINIA Network members. If you are already a member, log in with your password. If not, you can request access.

Access to AINIA Network

This area is exclusive to AINIA Network members. If you are already a member, log in with your password. If not, you can request access.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.